Skip to content
TrialScanner

NCT05824156

CM-101 in NASH Patients - The SPLASH Study

Phase 2CompletedCMMBLead

Registry record

Lead sponsor
ChemomAb Ltd.
Conditions
Nonalcoholic Steatohepatitis
Primary completion
Aug 15, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05824156 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05824156: CM-101 in NASH Patients... | TrialScanner